Diversity of Pathological Conditions Affecting Pituitary Stalk.

hypophysitis infundibulum pituitary stalk tumour

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
14 Apr 2021
Historique:
received: 01 03 2021
revised: 31 03 2021
accepted: 12 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Pituitary stalk lesions (PSL) are a very rare pathology. The majority of conditions affecting the infundibulum do not present with clinically apparent symptoms, what makes the diagnosis difficult. The recognition might be also complicated by the non-specific and transient characteristics of hormonal insufficiencies. In our study, we retrospectively analysed demographic, biochemical, and clinical long-term data of 60 consecutive, unselected adult patients (34 women and 26 men) with PSL diagnosed in the Department of Endocrinology, Jagiellonian University in Krakow. The diagnosis of PSL were categorized as confirmed, probable, or undetermined in 26, 26 and 8 patients, accordingly. Given the possible aetiology congenital, inflammatory, and neoplastic stalk lesions were diagnosed in 17, 15 and 20 patients, accordingly. In eight cases the underlying pathology remained undetermined. The most common pituitary abnormality was gonadal insufficiency diagnosed in 50.8% of cases. Diabetes insipidus was detected in 23.3% of cases. In 5% of patients the pituitary function recovered partially over time. Stalk lesions were extensively discussed in the context of the current literature. Based on the published data and our own experience a diagnostic algorithm has been proposed to help physicians with the management of patients with this challenging condition.

Identifiants

pubmed: 33920036
pii: jcm10081692
doi: 10.3390/jcm10081692
pmc: PMC8071026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Endocr Connect. 2018 Aug 23;:
pubmed: 30139817
Neurosurg Clin N Am. 2003 Jan;14(1):55-80, vi
pubmed: 12690979
Pediatr Blood Cancer. 2006 Feb;46(2):228-33
pubmed: 16047354
Cancer. 2004 Dec 1;101(11):2605-13
pubmed: 15495181
Endocr Rev. 2005 Aug;26(5):599-614
pubmed: 15634713
Eur J Hum Genet. 2010 Apr;18(4):393-7
pubmed: 19623216
Clin Endocrinol (Oxf). 2016 Oct;85(4):507-21
pubmed: 26950774
N Engl J Med. 2018 Aug 30;379(9):856-868
pubmed: 30157397
Pituitary. 2008;11(3):293-7
pubmed: 17638085
Eur J Endocrinol. 2013 Jan 17;168(2):211-7
pubmed: 23152438
Neuro Oncol. 2012 Sep;14(9):1194-200
pubmed: 22869621
CNS Oncol. 2015;4(4):273-9
pubmed: 26118663
Exp Ther Med. 2017 Jun;13(6):3474-3478
pubmed: 28587427
Pediatr Blood Cancer. 2004 Oct;43(5):594-9
pubmed: 15382278
J Pediatr Neurosci. 2014 May;9(2):188-91
pubmed: 25250085
AJR Am J Roentgenol. 2007 Mar;188(3):W223-32
pubmed: 17312027
J Cell Mol Med. 2017 Dec;21(12):3626-3632
pubmed: 28707430
Br J Neurosurg. 2001 Jun;15(3):242-5, discussion 245-6
pubmed: 11478060
J Clin Endocrinol Metab. 2015 Oct;100(10):3841-9
pubmed: 26262437
Cancer. 2004 Aug 1;101(3):613-9
pubmed: 15274075
AJNR Am J Neuroradiol. 2010 Feb;31(2):355-9
pubmed: 19797792
Acta Neurochir (Wien). 2013 Jan;155(1):119-24; discussion 124
pubmed: 23108562
J Clin Endocrinol Metab. 2013 May;98(5):1812-8
pubmed: 23533231
Neurochirurgia (Stuttg). 1990 Jul;33(4):127-31
pubmed: 2203980
Endocr Rev. 2006 Jun;27(4):371-97
pubmed: 16543382
Nat Rev Endocrinol. 2011 Jan;7(1):54-9
pubmed: 21102546
Pituitary. 2018 Dec;21(6):605-614
pubmed: 30276501
Korean J Radiol. 2001 Oct-Dec;2(4):222-30
pubmed: 11754330
Pituitary. 2015 Feb;18(1):159-68
pubmed: 24445565
Am J Hum Genet. 2002 Nov;71(5):1017-32
pubmed: 12395298
J Clin Endocrinol Metab. 2000 Apr;85(4):1370-6
pubmed: 10770168
Trends Endocrinol Metab. 2007 Aug;18(6):252-7
pubmed: 17600725
Lancet. 2003 Apr 12;361(9365):1293-5
pubmed: 12699969
AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1116-8
pubmed: 10871024
Endocrine. 2014 Sep;47(1):325-35
pubmed: 24532100
Horm Res Paediatr. 2013;79(5):283-92
pubmed: 23689058
Pediatr Endocrinol Diabetes Metab. 2019;25(3):155-162
pubmed: 31769274
Neuroradiology. 2006 Jan;48(1):37-44
pubmed: 16292545
J Endocrinol Invest. 2019 Apr;42(4):371-384
pubmed: 30030746
Endokrynol Pol. 2020;71(1):104-105
pubmed: 31681974
AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1999-2004
pubmed: 14625222
QJM. 2016 Nov;109(11):703-708
pubmed: 27131387
Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):339-45
pubmed: 18594274

Auteurs

Łukasz Kluczyński (Ł)

Department of Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Aleksandra Gilis-Januszewska (A)

Department of Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Magdalena Godlewska (M)

Department of Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Małgorzata Wójcik (M)

Department of Paediatric and Adolescent Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Agata Zygmunt-Górska (A)

Department of Paediatric and Adolescent Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Jerzy Starzyk (J)

Department of Paediatric and Adolescent Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Alicja Hubalewska-Dydejczyk (A)

Department of Endocrinology, Faculty of Medicine, Medical College, Jagiellonian University, 31-008 Krakow, Poland.

Classifications MeSH